The global cardiomyopathy market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to hold significant growth. For instance, In April 2022, LianBio’s and Bristol-Myers Squibb partnered and developed Camzyos medicine which has been approved by U.S. Food and Drug Administration (FDA). 

The global cancer biomarker market is anticipated to grow at a considerable CAGR of 5.1% during the forecast period. The major factor contributing to the growth of the market is the rising adoption of several R&D activities by the key market players along with FDA approvals across the globe For instance, in March 2021, Roche announced that the VENTANA ALK (D5F3) CDx Assay has been approved as a companion diagnostic by the US Food and Drug Administration. This assay test is the only one approved by the FDA as a companion diagnostic for LORBRENA, and it will aid in quickly identifying patients with this cancer biomarker so that they can receive more effective treatment.

The global artificial photosynthesis market is anticipated to grow at a considerable CAGR of 12% during the forecast period (2022-2030). The major factor contributing to the market growth are technological development, and rising funding and investment activities in artificial photosynthesis are creating the future opportunity for commercialization and market growth. 

The global aortic valve replacement market is anticipated to grow at a considerable CAGR of 11.2% during the forecast period. The new launches in the market along with increasing FDA approvals are contributing to the growth of the global market. Various companies such as Medtronic PLC, Boston Scientific Corp., Abbott Laboratories Inc., and others received approval for their advanced aortic heart valves as these companies can commercialize their products and gain a strong position in the market. 

The global selenium yeast market is anticipated to grow at a significant CAGR of 3.2% during the forecast period (2021-2028).  The major driving factor that enhances the market growth is rising chronic diseases which result in higher blood pressure levels, increasing mental health problems such as memory loss, and an increasing number of asthma patients.  A diet rich in selenium aids in keeping the heart healthy, and consuming selenium yeast improves memory in patients with Alzheimer's. For instance, according to Alz.org, in 2022 1 in 3 seniors dies with Alzheimer's or another dementia, and over 11 million Americans provide unpaid care for people with Alzheimer's. Hence, the rising prevalence of various diseases,  and the benefits offered by selenium rice foods enhance the growth of the global selenium yeat market.

The global mental health apps market is anticipated to grow at a considerable CAGR of 8.5% during the forecast period (2022-2028). Over the past few years several experts, and business leaders are continually expressing stressed the importance of mental health and well-being of employees in various industries. Moreover, education schools and institutes has also partnered with app developers to help their students cope with stress while studying hours, which is the major factor that has augmented the demand and development of mental apps. 

The global nasal drug delivery market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace this is anticipated to positively impact significant market growth. 

Global digital diabetes management market is anticipated to grow at a CAGR of 14.6% during the forecast period (2024-2031). The rising diabetes prevalence among the population with the growing digitalization of the healthcare sector has driven the global digital diabetes management market. The ongoing developments in the digital diabetes management industry are key factors driving the growth of the global market.

The global capsule filler market is anticipated to grow at a substantial CAGR of 4.7% during the forecast period (2022-2028). The increased awareness among the people regarding their health and beauty is driving the growth of capsule filler market across the globe. The usage of capsule filling machine or fillers is increased in cosmetic products and nutraceutical products filling. According to NCBI, nutraceutical products has physiological benefit or provides protection against chronic disease which increases the demand of the product. 

The global beauty devices market is anticipated to grow at a significant CAGR of 19.6% during the forecast period (2022-2028). The demand for hair removal devices is increasing during the forecast period due to which the beauty devices market witnesses growth globally. Further, the technological advancement in beauty devices and implementation of new features attract customers due to which the usage of beauty devices increases, and the beauty devices market grows during the forecast period. For instance, in May 2020, Lira Style, a Chicago-based medical device company launched the newest platform, the Cervello.